Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 13, 2018 | Orchard Therapeutics | $150.0M Series C | Elise Wang | Agent Capital, ArrowMark Partners, Cormorant Asset Management, Cowen Healthcare Investments, Driehaus Capital Management, Foresite Capital, Medison Ventures, Perceptive Advisors, RA Capital Management, RTW Investments, Sphera Healthcare, Temasek, Venrock |